1-3 of 3
K Tobal
Close
Sort by
Journal Articles

Systematic Evaluation of DNA-Based Quantitative-Polymerase Chain Reaction (Q-PCR) Assays to Track Treatment Response in Patients with JAK2-V617F Associated Myeloproliferative Neoplasms: A Joint European LeukemiaNet/ MPN&MPNr-EuroNet Study

J V Jovanovic, A M Vannucchi, E Lippert, E Oppliger Leibundgut, N Maroc, S Hermouet, G Nickless, B Cassinat, P Guglielmelli, B van der Reijden, A Bench, K Tobal, B Wilkins, K Cuthill, A Ivey, K Yeoman, M J Percy, S Schwemmers, A Gruender, T W Kelley, S Reading, A Pancrazzi, MF McMullin, H L Pahl, C N Harrison, J T Prchal, C Chomienne, JJ Kiladjian, T Barbui, D Grimwade
Journal: Blood
Blood (2011) 118 (21): 2812.
https://doi.org/10.1182/blood.V118.21.2812.2812
Published: 2011
Journal Articles

Molecular quantitation of minimal residual disease in acute myeloid leukemia with t(8;21) can identify patients in durable remission and predict clinical relapse

K. Tobal, J. Newton, M. Macheta, J. Chang, G. Morgenstern, P. A. S. Evans, G. Morgan, G. S. Lucas, J. A. Liu Yin
Journal: Blood
Blood (2000) 95 (3): 815–819.
https://doi.org/10.1182/blood.V95.3.815.003k30_815_819
Published: 2000
Journal Articles

Monitoring of minimal residual disease by quantitative reverse transcriptase-polymerase chain reaction for AML1-MTG8 transcripts in AML-M2 with t(8; 21)

K Tobal, JA Yin
Journal: Blood
Blood (1996) 88 (10): 3704–3709.
https://doi.org/10.1182/blood.V88.10.3704.bloodjournal88103704
Published: 1996